Difficulty: Medium
Average Score: 68%
Practice
The patient underwent an allograft renal transplant 48 hours earlier and is showing signs of rejection. What drug would the nurse expect the physician to order?
Correct answer
A
Rationale
The correct answer is A: Muromonab. Muromonab is a monoclonal antibody that targets T-lymphocytes and is used to treat acute rejection in organ transplant patients. It works by suppressing the immune response against the transplanted organ. In this case, the patient showing signs of rejection after an allograft renal transplant would benefit from Muromonab to prevent further rejection.
Other choices are incorrect:
B: Anakinra is an interleukin-1 receptor antagonist used for conditions like rheumatoid arthritis, not for transplant rejection.
C: Mycophenolate is an immunosuppressant that prevents organ rejection by inhibiting T and B cell proliferation, but it is not typically used for acute rejection.
D: Sirolimus is an mTOR inhibitor used for maintenance immunosuppression, not for acute rejection treatment.
Other choices are incorrect:
B: Anakinra is an interleukin-1 receptor antagonist used for conditions like rheumatoid arthritis, not for transplant rejection.
C: Mycophenolate is an immunosuppressant that prevents organ rejection by inhibiting T and B cell proliferation, but it is not typically used for acute rejection.
D: Sirolimus is an mTOR inhibitor used for maintenance immunosuppression, not for acute rejection treatment.